Parkinson disease (PD) is a neurodegenerative disorder characterized by the accumulation of α-synuclein into Lewy bodies. 3-Benzylidine-indolin-2-one represents a class of compounds, which are known to inhibit the accumulation of α-synuclein. In this paper, we report the synthesis of [13C] and [15N] labelled 1-benzyl-(Z)-3-(benzylidene)indolin-2-one from commercially available [13C2]-chloroacetic acid and [15N]-aniline in five steps. The product will be used to study its metabolites in human liver microsomes by liquid chromatography-tandem mass spectrometry.
帕
金森病(PD)是一种神经退行性疾病,其特征是α-突触核蛋白在路易小体中的积累。3-苄亚基
吲哚-2-酮代表了一类已知能够抑制α-突触核蛋白积累的化合物。在本文中,我们报告了从商业可得的[13C2]-
氯乙酸和[15N]-
苯胺合成标记有[13C]和[15N]的1-苄基-(Z)-3-(苄亚基)
吲哚-2-酮的五步法。该产物将用于通过
液相色谱-串联质谱法研究其在人肝微粒体中的代谢物。